CH, detected with increased frequency as humans age, is associated with known driver events: either somatic variants in genes recurrently mutated in myeloid cancers (for example, DNMT3A, TET2 and ASXL1), or chromosomal copy number alterations18–26. The gene discussed is TET2; the disease is cyclic hematopoiesis.